Intravenous Administration of RGI-2001 in Patient Undergoing Allogenic Hematopoietic Stem Cell Transplantation (AHSCT)

This study is currently recruiting participants. (see Contacts and Locations)
Verified June 2013 by Regimmune Inc.
Sponsor:
Collaborator:
Pacific-Link Regulatory Consulting LLC
Information provided by (Responsible Party):
Regimmune Inc.
ClinicalTrials.gov Identifier:
NCT01379209
First received: June 17, 2011
Last updated: June 27, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: August 2013
  Estimated Primary Completion Date: June 2013 (Final data collection date for primary outcome measure)